BEDFORD, Mass., Oct. 14 /PRNewswire/ -- John Santini, Jr., PhD, CEO of
MicroCHIPS, Inc., is named by Popular Science magazine as a member of the
2008 class of "young geniuses shaping the future of science." In the
history of this annual list, Dr. Santini is the only honoree who is also a
successful life sciences entrepreneur running his own commercial venture.
His company, MicroCHIPS, is pioneering intelligent medical devices for drug
delivery and biochemical sensing.
(Photo: http://www.newscom.com/cgi-bin/prnh/20081014/NETU106 )
Dr. Santini began developing the microreservoir technologies that are
at the core of his company's products as a doctoral student in the labs of
Dr. Robert Langer and Dr. Michael Cima at the Massachusetts Institute of
Technology. He founded MicroCHIPS with Drs. Langer and Cima as well as
Terry McGuire of Polaris Venture Partners in 1999. MicroCHIPS is developing
next-generation biosensing and drug delivery devices to increase
therapeutic control and effectiveness for people with diabetes,
osteoporosis and other debilitating diseases.
"I am honored to be a part of a list of such accomplished individuals,"
said Dr. Santini, President and CEO, MicroCHIPS. "It is exciting to see our
unique technologies take shape as products that can transform how
clinicians and patients manage serious, chronic conditions."
"It is gratifying to see how John is helping to move microreservoir
technology from 'bench to the bedside,'" said Robert Langer, ScD.,
Institute Professor at MIT. "He is working to realize our vision of
innovative long-term devices that can deliver drugs and sense chemicals
with exquisite control."
Under Dr. Santini's leadership, MicroCHIPS plans to begin clinical work
in 2009 for its lead products, a long-term continuous glucose monitor for
diabetes, and a drug delivery device for osteoporosis.
About MicroCHIPS
MicroCHIPS, Inc. is pioneering intelligent implanted devices designed
to improve the health of millions of people with chronic conditions that
require careful monitoring and precise therapy. Based on proprietary
microreservoir technology first developed at MIT, MicroCHIPS' platform
incorporates long-term implant technologies and wireless communications, as
well as expertise in protein and peptide formulation for challenging
delivery conditions. MicroCHIPS' technologies are designed to transform
electromechanical medical devices into highly tuned biochemical sensing and
therapy systems. http://www.mchips.com
About Popular Science's Annual "Brilliant 10"
For the past six years, Popular Science has published an article called
"Popular Science's Brilliant 10," in which the magazine profiles ten young
scientists doing work that is pushing their field to the next level. To
choose the ten recipients the editors contact hundreds of individuals,
including heads of departments at universities around the country,
professional associations and award-granting institutions.
SOURCE MicroCHIPS, Inc.
 back to top
Related links:
http://www.mchips.com
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/20081014/NETU106
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
CONTACT:
Maggie A. Pax, Vice President, Business
Development of MicroCHIPS, Inc., +1-781-275-1445 ext. 220,
mpax@mchips.com
|
